AYUVA

Serial Number 99269432
680

Registration Progress

Application Filed
Jul 7, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AYUVA

Basic Information

Serial Number
99269432
Filing Date
July 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
680
Status Date
Dec 11, 2025
Application
Pending
Classes
042

Rights Holder

Ayureon, Inc

03
Address
12117 Bee Caves Road
Suite 180
Austin, TX 78738

Ownership History

Ayureon, Inc

Original Applicant
03
Austin, TX

Application History

9 events
Date Code Type Description Documents
Dec 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 11, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 11, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 11, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 11, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 24, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 7, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 7, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Software as a service (SAAS) services in the nature of hosting cloud-based software of others; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for analyzing data and interacting with humans; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for clinical decision support; Providing temporary use of non-downloadable software utilizing artificial intelligence (AI) for clinical decision support and for managing telehealth communications; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing, interpreting, and visualizing laboratory results and patient health data; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing symptoms, medical history, and clinical data to suggest potential diagnoses and treatment pathways
First Use Anywhere: Jul 7, 2025
First Use in Commerce: Jul 7, 2025

Classification

International Classes
042